Chargement en cours...
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
BACKGROUND: New biomarkers are needed for the prognosis of advanced colorectal cancer, which remains incurable by conventional treatments. O(6)-methylguanine DNA methyltransferase (MGMT) methylation and protein expression have been related to colorectal cancer treatment failure and tumor progression...
Enregistré dans:
| Publié dans: | BMC Cancer |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4227111/ https://ncbi.nlm.nih.gov/pubmed/25015560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-511 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|